Entero Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Entero Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2015 to Q3 2024.
  • Entero Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 4.74M shares, a 64.8% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 4.74M -8.72M -64.8% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 2.94M -1.27M -30.1% Jun 30, 2024 10-Q 2024-10-21
Q1 2024 2.03M +476K +30.7% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 1.56M +1.51M +3038% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 13.5M +11.2M +484% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 4.21M -18.5M -81.5% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 1.55M -20M -92.8% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 49.8K -21K -29.7% Dec 31, 2022 10-K 2024-03-29
Q3 2022 2.31M -8.81M -79.2% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 22.7M -59.9M -72.5% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 21.5M -53.4M -71.2% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 70.7K -3.04M -97.7% Dec 31, 2021 10-K 2023-03-20
Q3 2021 11.1M -17.8M -61.5% Sep 30, 2021 10-Q/A 2021-11-16
Q2 2021 82.6M +54.1M +190% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 74.9M +47.8M +176% Mar 31, 2021 10-Q 2021-05-24
Q4 2020 3.12M -23.7M -88.4% Dec 31, 2020 10-K 2022-03-31
Q3 2020 28.9M 0 0% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 28.5M +7.4M +35.1% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 27.2M +8.62M +46.5% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 26.8M +9.1M +51.4% Dec 31, 2019 10-K 2021-03-31
Q3 2019 28.9M +11.9M +70.5% Sep 30, 2019 10-Q 2020-11-16
Q2 2019 21.1M +4.31M +25.7% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 18.5M +5.94M +47.1% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 17.7M +5.66M +47% Dec 31, 2018 10-K 2020-03-30
Q3 2018 16.9M +5.52M +48.3% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 16.8M +5.67M +51% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 12.6M +2.97M +30.9% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 12M +2.41M +25% Dec 31, 2017 10-K 2019-04-01
Q3 2017 11.4M +5.39M +89.4% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 11.1M Jun 30, 2017 10-Q 2017-08-14
Q1 2017 9.63M Mar 31, 2017 10-Q 2017-05-15
Q4 2016 9.63M +5.33M +124% Dec 31, 2016 10-K 2018-03-16
Q3 2016 6.03M Sep 30, 2016 10-Q 2016-11-25
Q4 2015 4.3M Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.